Recent articles
MediPharm Labs Signs Supply Agreement With Online Medical Cannabis Portal
MediPharm will supply Medical Cannabis by Shoppers with oils, gel caps, and topicals.
Insulet Announces Agreements With Abbott and DexCom
Insulet's wearable insulin pumps will be integrated with blood glucose monitors from both companies.
Where Will Illumina Be in 1 Year?
The gene sequencing company's shares have been lagging. Will the situation be different a year from now?
Medtronic Misses on Top Line, but Beats Profit Expectations
Management warned that the COVID-19 outbreak will affect next quarter's results, but did not speculate as to how big the impact would be.
Insulet Issues a Medical Device Correction Notice for Insulin Pump System
The company will replace its Omnipod DASH Personal Diabetes Managers next month to correct a software problem.
ImmunoGen Beats Expectations and Fuels Optimism for Its Lead Drug Candidate
Cost-cutting led to a surprise profit, and the company outlined the path ahead for its pipeline treatment for ovarian cancer.
Is Takeda Pharmaceutical Company Stock a Buy?
A huge acquisition could get this overlooked giant on investors' radar.
A Double Failure of Alzheimer's Drugs
Lilly and Roche reported their latest disappointments in attempting to effectively treat Alzheimer's by attacking amyloid plaques.
Gene-Editing IPO Gets Warm Reception From Investors
Beam Therapeutics' new approach offers more precision than CRISPR.
Regeneron Shares Rise on Earnings, Coronavirus Work
Two drugs drove its fourth-quarter sales growth, and the company expects to have an experimental treatment for 2019n-CoV coronavirus in a few months.
AbbVie Reports Successful Trial Results for Arthritis Drug
A future blockbuster scores another success as AbbVie works to replace Humira losses.
Merck Announces a Big Planned Spinoff
The pharma giant will form a new publicly traded company out of its women's health and biosimilars businesses, and its legacy brands.
Phibro Animal Health Soars on Better-Than-Expected Earnings
The company raised guidance, and also raised hopes about its vaccine candidate for African swine fever.
Takeda Pharmaceutical Raises Its Profit Outlook
The integration of Shire is progressing more quickly than the company had expected.
FDA Approves First Drug for Peanut Allergy
The first approved drug for any food allergy may be the first of several from Aimmune Therapeutics.
Merck's Insomnia Drug Approved for Alzheimer's Patients
Trouble sleeping is common among sufferers of Alzheimer's disease.
3 Growth Stocks for Low-Risk Investors
These companies offer growth at a reasonable price and could hold up in a downturn.
Eli Lilly Launches a New Migraine Drug
Reyvow is the first drug in an entirely new class of acute migraine treatments.
Pfizer's Q4 Results, 2020 Guidance Leave Investors Cold
The impact of generic competition for Lyrica was expected, but investors saw other things in the quarterly report that concerned them.
Is Zoetis Stock a Buy?
Solid growth prospects make this animal health company an investor favorite, but don't forget to examine the price you'd pay.